Focal Dystonia Clinical Trial
Official title:
fMRI Studies of Task Specificity in Focal Hand Dystonia
Verified date | March 13, 2012 |
Source | National Institutes of Health Clinical Center (CC) |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This study will examine how the brain makes involuntary spasms and contractions in patients
with focal hand dystonia (FHD). Patients with dystonia have muscle spasms that cause
uncontrolled twisting and repetitive movement or abnormal postures. In FHD, only the hand is
involved. The study will use functional magnetic resonance imaging (fMRI, see below) to study
which areas of the brain are primarily affected in FHD and better understand how brain
changes produce dystonia symptoms.
Normal right-handed volunteers and patients with FHD who are 18-65 years of age may be
eligible for this study. Candidates are screened with a medical history and physical and
neurological examinations. Women who can become pregnant have a urine pregnancy test.
All participants undergo fMRI. This test uses a strong magnetic field and radio waves to
obtain images of body organs and tissues. The subject lies on a table that is moved into the
scanner (a metal cylinder), wearing earplugs to muffle loud knocking and thumping sounds that
occur during the scanning process. The procedure lasts about 90 minutes, during which time
the patient is asked to lie still for 10-15 minutes at a time. During the procedure, subjects
are asked to perform some tasks, including writing, tapping with their hand, and drawing in a
zigzag motion. Each task is performed using the right hand, left hand and right foot.
Status | Completed |
Enrollment | 51 |
Est. completion date | March 13, 2012 |
Est. primary completion date | |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility |
- INCLUSION CRITERIA: Focal Dystonia Subjects must be: - Right hand dominant - Between 18 and 65 years old - Diagnosed with mild, simple focal hand dystonia. For this study mild, simple focal hand dystonia suggests that the patient does not present symptoms when performing tasks other than writing. Additionally, the patient should be able to write for 20 seconds consecutively - Willing to abstain from alcohol 48 hours prior to the study Volunteers must be: - Healthy right-handed dominant individuals - Between 18 and 65 years old - Willing to abstain from alcohol 48 hours prior to the study EXCLUSION CRITERIA: - Subjects with implanted devices such as pacemakers, medication pumps or defibrillators, metal in the cranium except mouth, intracardiac lines, history of shrapnel injury or any other condition/device that may be contraindicated or prevent the acquisition of MRI - Subjects with any finding on the MRI safety questionnaire which prevents them from safely undergoing an MRI scan - Subjects who are pregnant. - Subjects with claustrophobia or other restrictions which prevent them from undergoing a scan in a confined space for up to 60 minutes - Subjects with any visual, motor, or hearing difficulties - Subjects with severe focal hand dystonia i.e., subjects who experience dystonic spasms in tasks other than/in addition to writing - Subjects with mirror dystonia - Subjects without the capacity to give consent - Subjects with any history of a severe medical condition, such as cardiovascular disease, which will prevent them from lying flat for up to 60 minutes. - Subjects with any history of brain tumor, stroke, head trauma or vascular malformation as obtained by history or from imaging studies. - Subjects who have had recent (within 3 months) Botulinum Toxin (Botox) injections. - Subjects who are on anti-parkinsonian drugs |
Country | Name | City | State |
---|---|---|---|
United States | National Institutes of Health Clinical Center, 9000 Rockville Pike | Bethesda | Maryland |
Lead Sponsor | Collaborator |
---|---|
National Institute of Neurological Disorders and Stroke (NINDS) |
United States,
Berardelli A, Rothwell JC, Hallett M, Thompson PD, Manfredi M, Marsden CD. The pathophysiology of primary dystonia. Brain. 1998 Jul;121 ( Pt 7):1195-212. Review. — View Citation
Blood AJ, Flaherty AW, Choi JK, Hochberg FH, Greve DN, Bonmassar G, Rosen BR, Jenkins BG. Basal ganglia activity remains elevated after movement in focal hand dystonia. Ann Neurol. 2004 May;55(5):744-8. — View Citation
Butterworth S, Francis S, Kelly E, McGlone F, Bowtell R, Sawle GV. Abnormal cortical sensory activation in dystonia: an fMRI study. Mov Disord. 2003 Jun;18(6):673-82. — View Citation
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04692285 -
Electrophysiological and Neuroimaging Correlates of the Effect of Zolpidem in Patients With Focal Dystonia
|
Phase 1 | |
Completed |
NCT00505323 -
Motor and Premotor Cortex Stimulation for Treatment of Secondary Focal Dystonia With Striato Palliadal Lesion : Evaluation of Safety and Effectiveness
|
Phase 1 | |
Terminated |
NCT03206112 -
Loss of Depotentiation in Focal Dystonia
|
||
Completed |
NCT00025701 -
EEG and EMG Studies of Hand Dystonia
|
N/A | |
Completed |
NCT02334683 -
Compare Two Guidance Techniques for Botulinum Toxin Injections for the Treatment of Limb Spasticity and Focal Dystonia
|
N/A | |
Completed |
NCT03797638 -
Characterization of Manual Dexterity by Finger Force Manipuladum (FFM) in Patients With Writer's Cramp and in Control Subjects
|
N/A | |
Terminated |
NCT01750346 -
Acetyl Hexapeptide-8 for Blepharospasm
|
Phase 2 | |
Completed |
NCT01738581 -
rTMS and Retraining in Focal Hand Dystonia
|
Phase 1/Phase 2 | |
Terminated |
NCT02106936 -
Depotentiation in People With Focal Hand Dystonia
|
N/A | |
Completed |
NCT00309010 -
Neurophysiology of Task-Specificity of Focal Hand Dystonia
|
N/A | |
Completed |
NCT03471923 -
Non-Motor Features of Cervical Dystonia (CD)
|
||
Completed |
NCT00306865 -
Brain Changes in Patients With Focal Hand Dystonia
|
N/A | |
Completed |
NCT00411255 -
Brain Stimulation to Treat Blepharospasm or Meige Syndrome
|
Phase 2 | |
Terminated |
NCT00487383 -
Brain Changes in Blepharospasm
|
||
Recruiting |
NCT05095740 -
Effects of Neuromodulation in Laryngeal Dystonia
|
N/A | |
Completed |
NCT00713414 -
Role of Neurotransmission and Functional CNS Networks in Spasmodic Dysphonia
|
||
Completed |
NCT00942851 -
A Study of Acetyl Hexapeptide-8 (AH8) in Treatment of Blepharospasm
|
Phase 1/Phase 2 | |
Completed |
NCT00118586 -
Neuropathology of Spasmodic Dysphonia
|
||
Completed |
NCT02326818 -
Comparison of Electrophysiologic and Ultrasound Guidance for Onabotulinum Toxin A Injections in Focal Upper Extremity Dystonia and Spasticity
|
Phase 3 | |
Active, not recruiting |
NCT02911103 -
Deep Brain Stimulation Surgery for Focal Hand Dystonia
|
Phase 1/Phase 2 |